Subcellular localization of Klf4 in non-small cell lung cancer and its clinical significance
Open Access
- 1 March 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 99, 480-485
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U1504820)
This publication has 27 references indexed in Scilit:
- OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinomaBiochemical Pharmacology, 2017
- Krüppel-like factors in cancerNature Reviews Cancer, 2013
- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factorsOncogene, 2013
- Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the GenomeCell, 2012
- Disruption of Klf4 in Villin-Positive Gastric Progenitor Cells Promotes Formation and Progression of Tumors of the Antrum in MiceGastroenterology, 2012
- mTOR inhibitor rapamycin alone or combined with cisplatin inhibits growth of esophageal squamous cell carcinoma in nude miceCancer Letters, 2010
- First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer: A Systematic ReviewJournal of Thoracic Oncology, 2010
- The new World Health Organization classification of lung tumoursEuropean Respiratory Journal, 2001
- Non–Small-Cell Lung Cancer — Stalemate or Progress?New England Journal of Medicine, 2000
- Comparative Study of p53 Expression in Primary Invasive Ductal Carcinoma of the Pancreas Between Chinese and JapanesePancreas, 1998